Agios Pharmaceuticals Inc (AGIO)
30.21
+0.68
(+2.30%)
USD |
NASDAQ |
Apr 22, 16:00
30.23
+0.02
(+0.07%)
After-Hours: 20:00
Agios Pharmaceuticals Gross Profit (Quarterly): 6.517M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 6.517M |
September 30, 2023 | 6.766M |
June 30, 2023 | 5.604M |
March 31, 2023 | 5.055M |
December 31, 2022 | 3.897M |
September 30, 2022 | 2.999M |
June 30, 2022 | 5.147M |
March 31, 2022 | 0.493M |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 |
Date | Value |
---|---|
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | 25.63M |
June 30, 2019 | 25.92M |
March 31, 2019 | 29.89M |
December 31, 2018 | 29.31M |
September 30, 2018 | 14.50M |
June 30, 2018 | 40.41M |
March 31, 2018 | 8.762M |
December 31, 2017 | 9.799M |
September 30, 2017 | 11.36M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
--
Minimum
Mar 2021
25.92M
Maximum
Jun 2019
6.288M
Average
4.476M
Median
Gross Profit (Quarterly) Benchmarks
Alnylam Pharmaceuticals Inc | 353.86M |
Blueprint Medicines Corp | 71.70M |
Corcept Therapeutics Inc | 133.53M |
Ionis Pharmaceuticals Inc | 321.44M |
Madrigal Pharmaceuticals Inc | -- |